Skip to content
  1. Home
  2. Latest news
  3. Caring & giving
  4. Bridge to Employment: 25 years of helping young people excel in school—and life
A photo of a group from Bridge to Employment

Bridge to Employment: 25 years of helping young people excel in school—and life

This Johnson & Johnson program pairs high school kids with local companies and institutes of higher learning to help set them up for success in the work world. We take a look at the inspiring statistics behind that success.

Since 1992, Johnson & Johnson’s Bridge to Employment (BTE) program has provided high schoolers with meaningful educational experiences and career prep to help set them up for success as they head off to college.

In the last 25 years, BTE has come a long way: What started as a U.S.-based program has expanded well beyond its domestic roots to encompass over 80 sites in more than 20 countries, including India, Israel, Mexico, South Africa and Spain.

Earlier this year, in fact, Johnson & Johnson India was honored with the prestigious Global CSR Leadership Award for Innovation in Corporate Social Responsibility Practices for its work mentoring 50 underprivileged students in Mumbai through the BTE program.

As the latest class of students graduates from the program on June 21, we’re taking a look at the impact BTE has had over the last quarter-century around the globe.


Johnson & Johnson’s Bridge to Employment Program

More from Johnson & Johnson

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.

What is lupus?

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.

This scientist develops targeted treatments for cancer—here’s what drives and inspires him

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.